Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the bioequivalence of atenolol formulations after
administration of single doses to normal healthy subjects under fasted conditions. These data
were to be evaluated statistically to determine if the products meet bioequivalence criteria.